1 Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132. 2 Berindan Neagoe I,Monroig PC,Pasculli B,et al.MicroRNAome genome:a treasure for cancer diagnosis and therapy[J].Cancer J Clinicians,2014,64(5):311-336. 3 Kouso H,Yano T,Maruyama R,et al.Differences in the expression of epithelial-mesenchymal transition related molecules between primary tumors and pulmonary metastatic tumors in colorectal cancer[J].Surgery Today,2012,43(1):73-80. 4 Zhang D,Zhou J,Ming D.Dysregulation of microRNA-34a expression in colorectal cancer inhibits the phosphorylation of FAK via VEGF[J].Digest Dis Sci,2014,59(5):958-967. 5 Sahani DV,Bajwa MA,Andrabi Y,et al.Current status of imaging and emerging techniques to evaluate liver metastases from colorectal carcinoma[J].Annal Surgery,2014,259(5):861-872. 6 Lu J,Getz G,Miska EA,et al.MicroRNA expression profiles classify human cancers[J].Nature,2005,435(7043):834-838. 7 Cao W,Fan R,Wang L,et al.Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells[J].Tumor Biology,2013,34(2):963-971. 8 Si W,Li Y,Shao H,et al.MiR-34a inhibits breast cancer proliferation and progression by targeting Wnt1 in Wnt/β-catenin signaling pathway[J].Am J Med Sci,2016,352(2):191-199. 9 Li N,Fu H,Tie Y,et al.miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells[J].Cancer Letters,2009,275(1):44-53. 10 Gao J,Li N,Dong Y,et al.miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage Ⅱ/Ⅲ colorectal cancer[J].Oncogene,2015,34(31):4142-4152. 11 Nieto MA.Epithelial plasticity:a common theme in embryonic and cancer cells[J].Science,2013,342(6159):1234850. 12 Wrighton KH.Cell migration:EMT promotes contact inhibition of locomotion[J].Nat Rev Mol Cell Biol,2015,16(9):518. 13 Davalos V,Moutinho C,Villanueva A,et al.Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis[J].Oncogene,2012,31(16):2062-2074. |